Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 1

Conditions

Colonic Neoplasms 9Colorectal Neoplasms 8Rectal Neoplasms 6Stomach Neoplasms 5Esophageal Neoplasms 4Pancreatic Neoplasms 3Motor Activity 2Frailty 2Carcinoma, Hepatocellular 2Pancreatitis, Chronic 1Ovarian Neoplasms 1Nutrition Disorders 1Metabolic Syndrome 1Liver Neoplasms 1Liver Cirrhosis 1Insulin Resistance 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Cancer Surgery 1Disease 1

Interventions

pembrolizumab 50Cyclophosphamide 25Carboplatin 25Gemcitabine 20Cisplatin 19fludarabine 18Nivolumab 17Paclitaxel 16Bevacizumab 15Specimen Handling 14Fluorouracil 11Magnetic Resonance Spectroscopy 10aldesleukin 9Oxaliplatin 9Irinotecan 9Docetaxel 9Biopsy 9olaparib 8Trastuzumab 8durvalumab 7atezolizumab 7Hyperthermic Intraperitoneal Chemotherapy 7Albumin-Bound Paclitaxel 7Taxes 6Leucovorin 6Ipilimumab 6Interleukin-2 6Cetuximab 6Capecitabine 6130-nm albumin-bound paclitaxel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Preoperative Exercise × Gastrointestinal × Clear all
NCT05887531 2025-01-29

Abdominopelvic Cancer Prehabilitation

Universitat Jaume I

Phase NA Completed
66 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Ovarian Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡